487 related articles for article (PubMed ID: 34100388)
1. Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation.
Alqahtani SA; Barry M; Memish Z; Hashim A; Alfares MA; Alghamdi SA; Al-Hamoudi WK; Al-Judaibi B; Alhazzani W; Al-Tawfiq JA; Abaalkhail F
Saudi J Gastroenterol; 2021; 27(4):201-207. PubMed ID: 34100388
[TBL] [Abstract][Full Text] [Related]
2. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
3. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
[TBL] [Abstract][Full Text] [Related]
4. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
Thuluvath PJ; Robarts P; Chauhan M
J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993
[TBL] [Abstract][Full Text] [Related]
5. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of COVID-19 vaccines in chronic liver disease patients and liver transplant recipients: A systematic review and meta-analysis.
Luo D; Chen X; Du J; Mei B; Wang A; Kuang F; Fang C; Gan Y; Peng F; Yang X; Dahmen U; Li B; Song S
Liver Int; 2023 Jan; 43(1):34-48. PubMed ID: 35986903
[TBL] [Abstract][Full Text] [Related]
7. American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease.
Fix OK; Blumberg EA; Chang KM; Chu J; Chung RT; Goacher EK; Hameed B; Kaul DR; Kulik LM; Kwok RM; McGuire BM; Mulligan DC; Price JC; Reau NS; Reddy KR; Reynolds A; Rosen HR; Russo MW; Schilsky ML; Verna EC; Ward JW; Fontana RJ;
Hepatology; 2021 Aug; 74(2):1049-1064. PubMed ID: 33577086
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
9. Saudi association for the study of liver diseases and transplantation position statement on liver transplantation during the COVID-19 pandemic.
Al-Judaibi B; Almaghrabi R; Alghamdi M; Al-Hamoudi WK; AlQahtani M; Abaalkhail F; Shagrani M; Sanai FM
Saudi J Gastroenterol; 2020; 26(5):233-239. PubMed ID: 32341229
[TBL] [Abstract][Full Text] [Related]
10. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
[TBL] [Abstract][Full Text] [Related]
11. Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases.
Chauhan M; Nzeako I; Li F; Thuluvath PJ
Ann Hepatol; 2022; 27(4):100702. PubMed ID: 35338012
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis.
Cheung KS; Mok CH; Mao X; Zhang R; Hung IF; Seto WK; Yuen MF
Clin Mol Hepatol; 2022 Oct; 28(4):890-911. PubMed ID: 36263669
[TBL] [Abstract][Full Text] [Related]
13. Update on COVID-19 vaccination in pediatric solid organ transplant recipients.
Dulek DE; Ardura MI; Green M; Michaels MG; Chaudhuri A; Vasquez L; Danziger-Isakov L; Posfay-Barbe KM; McCulloch MI; L'Huillier AG; Benden C
Pediatr Transplant; 2022 Aug; 26(5):e14235. PubMed ID: 35060251
[TBL] [Abstract][Full Text] [Related]
14. Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety.
Svorcova M; Novysedlak R; Lischke R; Vachtenheim J; Strizova Z
Front Immunol; 2022; 13():906225. PubMed ID: 35720376
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus disease 2019 and the liver.
Esteban JP; Sobotka L; Rockey DC
Curr Opin Gastroenterol; 2022 May; 38(3):191-199. PubMed ID: 35275902
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 Vaccination.
Moon AM; Webb GJ; García-Juárez I; Kulkarni AV; Adali G; Wong DK; Lusina B; Dalekos GN; Masson S; Shore BM; Barnes E; Barritt AS; Marjot T
Hepatol Commun; 2022 Apr; 6(4):889-897. PubMed ID: 34708575
[TBL] [Abstract][Full Text] [Related]
17. Acceptance of SARS-CoV-2 vaccines by liver transplant recipients and candidates.
Reuken PA; Albers S; Rauchfuss F; Strnad P; Settmacher U; Trautwein C; Stallmach A; Bruns T
Z Gastroenterol; 2021 Dec; 59(12):1288-1296. PubMed ID: 34670294
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients.
Havlin J; Svorcova M; Dvorackova E; Lastovicka J; Lischke R; Kalina T; Hubacek P
J Heart Lung Transplant; 2021 Aug; 40(8):754-758. PubMed ID: 34120839
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of the BNT162b2 mRNA vaccine in heart transplant recipients - a prospective cohort study.
Itzhaki Ben Zadok O; Shaul AA; Ben-Avraham B; Yaari V; Ben Zvi H; Shostak Y; Pertzov B; Eliakim-Raz N; Abed G; Abuhazira M; Barac YD; Mats I; Kramer MR; Aravot D; Kornowski R; Ben-Gal T
Eur J Heart Fail; 2021 Sep; 23(9):1555-1559. PubMed ID: 33963635
[TBL] [Abstract][Full Text] [Related]
20. Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients.
Kulkarni AV; Jaggaiahgari S; Iyengar S; Simhadri V; Gujjarlapudi D; Rugwani H; Vemula VK; Gora BA; Shaik S; Sharma M; Sasikala M; Padaki NR; Rajender Reddy K; Reddy DN
Vaccine; 2022 Nov; 40(48):6971-6978. PubMed ID: 36374707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
